Precision BioSciences Inc
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -176.0% | -119.7% | -107.9% | -29.8% | -1,026.4% | -2,928.4% | -65,696.6% | -112,616.7% | -117,461.5% | -32.9% | -110.1% | – | -115.2% | |
| 15.5% | 22.1% | 8.1% | 2.8% | 175.5% | 118.7% | 2,431.0% | 3,866.7% | 5,184.6% | 2.0% | 5.9% | – | 5.8% | |
| 23.7% | 42.2% | 16.5% | 5.9% | 555.4% | 559.7% | 9,731.0% | 16,316.7% | 18,353.8% | 6.0% | 14.3% | – | 17.4% | |
| -96.6% | 42.0% | -115.6% | -89.1% | 1,718.6% | 141.2% | -4,465.5% | -14,561.1% | 14,500.0% | -64.9% | -54.0% | – | -52.3% | |
| 3.3% | 0.4% | 0.5% | 0.1% | 11.1% | 15.2% | 1,082.8% | 11.1% | 115.4% | 0.1% | 0.2% | – | 0.2% | |
| 57.7% | 0.6% | -0.1% | -0.1% | -11.1% | -15.2% | -1,082.8% | -66.7% | 130.8% | -1.0% | -1.1% | – | -0.9% | |
| – | – | – | – | – | -3.1% | – | – | – | 0.0% | – | – | – | |
| -0.3% | 40.2% | 228.0% | 1.4% | 648.1% | 927.9% | 36,851.7% | 29,444.4% | 12,761.5% | 226.6% | 6.9% | – | 179.0% | |
| -118.6% | -78.9% | 119.9% | -28.4% | -389.4% | -2,015.7% | -29,927.6% | -83,227.8% | -133,630.8% | 192.8% | -104.3% | – | 52.9% | |
| -179.3% | -119.3% | -108.4% | -29.9% | -1,037.5% | -2,943.6% | -66,779.3% | -112,627.8% | -117,461.5% | -33.0% | -110.3% | – | -115.3% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.